Events

Company Formation: avoiding mistakes, reducing costs and structuring for growth! Hearing from: Joseph Murphy - Caesar Rivise Intellectual Property Law Joseph Devine - Spector Gadon Rosen Vinci Harvey Hoffman - HZH Strategy, LLC Learn about: Selecting an appropriate legal entity early in development How to select and protect brand names, logos, domain names, etc. before you start creating value Documenting [...]

Not a finance expert? Not a problem! Join us for the FREE September edition of our Practical Knowledge Series. The topic is finance basics for scientists and first-time entrepreneurs.  Our panel of experts will explain words and phrases commonly found in terms sheets, help the audience understand the factors that influence a young company's value, [...]

Learn best practices and considerations relating to clinical trial design and how they can influence FDA approval from a group of experts. Stay tuned for more information! Remote Access: https://www.eventbrite.com/e/the-imporance-of-clinical-trials-design-tickets-74268907301

Learn what to consider when deciding  with whom to partner and when. Your expert panel includes Dr. John Younger of University City Science Center and Anthony Maher of University Place Associates Stay tuned for more information! Location: Webinar Remote Access will also be available!

Topics to include: • Accelerators vs. incubators – what’s the difference? •   What    facilities    and    services    can    I    expect    to    find? • Leaving the nest – what to do when you’ve outgrown  the incubator Submit questions through our registration process or  ask them during the broadcast!

Customer Discovery: Understanding Who Will Use, Buy and Benefit from Your Invention  You have an idea for a new product or service – great! Before spending precious limited resources developing the product take time to ensure there will be a sufficient market for what you build. Our panel of experts will talk about processes for [...]

Join BioStrategy Partners, our panel of experts, and your peers from the academic and entrepreneurial communities for a discussion about IP considerations of particular interest to life sciences professionals.

While peer review and replication of results have long been a hallmark of high-quality research, the scrutiny of results has intensified in recent years, particularly in situations where the technology is bound for licensing or acquisition. Competition, technological challenges, economic pressure, and rare but high-profile cases of fraud are all contributing to this phenomenon.